These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35810257)

  • 41. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review).
    Xin W; Wang Y; Hua K; Liu S
    Int J Mol Med; 2023 Aug; 52(2):. PubMed ID: 37449492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of the Prognostic Value and Potential Molecular Mechanisms of TREM-1 Overexpression in Papillary Thyroid Cancer
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
    Front Endocrinol (Lausanne); 2021; 12():646793. PubMed ID: 34122331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value and immune infiltration of novel signatures in colon cancer microenvironment.
    Lin Y; Pan X; Chen Z; Lin S; Shen Z; Chen S
    Cancer Cell Int; 2021 Dec; 21(1):679. PubMed ID: 34922547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypomethylation of lncRNA H19 as a potential prognostic biomarker for oral squamous cell carcinoma.
    Lee EY; Song JM; Kim HJ; Park HR
    Arch Oral Biol; 2021 Sep; 129():105214. PubMed ID: 34333230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
    Gugnoni M; Manicardi V; Torricelli F; Sauta E; Bellazzi R; Manzotti G; Vitale E; de Biase D; Piana S; Ciarrocchi A
    Thyroid; 2021 Feb; 31(2):247-263. PubMed ID: 32495722
    [No Abstract]   [Full Text] [Related]  

  • 48. Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
    Qi F; Tang J; Cai Z; Wang G; Wang Z
    Bioengineered; 2022 Mar; 13(3):7592-7606. PubMed ID: 35264071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Crit Rev Eukaryot Gene Expr; 2022; 33(1):1-14. PubMed ID: 36374807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
    Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
    Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.
    Pan H; Luo Z; Lin F; Zhang J; Xiong T; Hong Y; Sun B; Yang Y
    Oncol Lett; 2024 Nov; 28(5):510. PubMed ID: 39268167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
    Zhou H; Shen W; Zou H; Lv Q; Shao P
    J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
    Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
    Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Liang WQ; Zeng D; Chen CF; Sun SM; Lu XF; Peng CY; Lin HY
    Cancer Manag Res; 2019; 11():2059-2072. PubMed ID: 30881130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
    Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
    Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA ATP1A1-AS1 inhibits cell proliferation and promotes cell apoptosis in thyroid carcinoma by regulating the miR-620/IRF2BP2 axis.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Am J Med Sci; 2023 Jan; 365(1):73-83. PubMed ID: 36002076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
    Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
    World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.